Canada markets closed

Aileron Therapeutics, Inc. (ALRN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.9500+0.1900 (+5.05%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
3,991
3,991
17,967
17,008
11,166
Selling General and Administrative
11,357
11,357
9,680
9,597
9,330
Total Operating Expenses
15,348
15,348
27,647
26,605
20,496
Operating Income or Loss
-15,348
-15,348
-27,647
-26,605
-20,496
Total Other Income/Expenses Net
-728
-728
318
441
-700
Income Before Tax
-15,676
-15,676
-27,329
-26,164
-21,196
Income from Continuing Operations
-15,676
-15,676
-27,329
-26,164
-21,196
Net Income
-15,732
-15,732
-27,329
-26,164
-21,157
Net Income available to common shareholders
-15,732
-15,732
-27,329
-26,164
-21,157
Basic EPS
-2.85
-3.42
-6.02
-5.89
-12.20
Diluted EPS
-2.85
-3.42
-6.02
-5.89
-12.20
Basic Average Shares
4,541
4,599
4,539
4,440
1,743
Diluted Average Shares
4,541
4,599
4,539
4,440
1,743